Statins are the first choice treatment of dyslipidemia, a major contributor to cardiovascular
diseases. Statins also have enough evidence to demonstrate decrease of morbidity and
mortality from cardiovascular diseases. Even though statin therapy is effective treatment of
dyslipidaemia not all patients reach the goal levels.
The aim of the study is to estimate proportion of patients who achieved the therapeutic goal
(LDL-C. total cholesterol, HDL-C and triglycerides levels) after at least one year of a